| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |